Drug Profile
Bullatacin
Latest Information Update: 12 Mar 2008
Price :
$50
*
At a glance
- Originator Purdue University
- Developer Pharmacia Corporation; Purdue University
- Class Antineoplastics
- Mechanism of Action Electron transport complex I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation